New class action for Klarna Group plc (KLAR) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/20/2026.

NEW YORK--(BUSINESS WIRE)--BitGo Holdings Inc. (“BitGo”), the digital asset infrastructure company, today announced that it supported iPower Inc. (Nasdaq: IPW) in the execution and custody of its digital asset treasury transactions. iPower completed purchases of Bitcoin (BTC) and Ethereum (ETH) through an account maintained at BitGo Bank & Trust, National Association (“BitGo Bank & Trust”). The transactions were executed using BitGo Prime's over-the-counter (OTC) trading services, enabl.

RALEIGH, N.C.--(BUSINESS WIRE)--Advance Auto Parts Names OSRAM Sylvania Inc. Global 2025 Vendor Partner of the Year.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options

A German contractor, Italian aerospace name, and British defense company.

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares”) at a price of US$90.00 per Common Share for gross proceeds of US$175,050,000 (the “Offering”). In connection with the Offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 291,750 Common Shares at the public offering price, less underwriting discounts and commissions. All of the securities sold in this Offering were offered by …

I'm ugrading Karooooo Ltd. to a Buy on accelerating, profitable revenue growth and disciplined cost management. KARO's Logistics segment is outpacing Cartrack in its growth rate, driven by e-commerce and high customer retention, supporting a robust LTV to CAC of over 9x. Management highlights strong demand exceeding current onboarding capacity, with strategic expansion in Southeast Asia and Europe underway.

Rising global chip sales and AI-driven demand put ADI, NVDA, MTSI and ASYS in focus as semiconductor stocks gain momentum in a strong market.

JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic manufacturing.

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

PBF Energy soared 14% on a robust gap-and-go following a Piper Sandler upgrade to ‘Overweight' accompanied by a $40 price target. The catalyst mentioned was PBF‘s strategic advantage in increasing Venezuelan crude imports.

The U.S. involvement in Venezuela's oil sector offers a potential opportunity for international banks, with JPMorgan Chase in an advantageous spot due to its history in the country and past involvement with international trade financing.

Despite tariff worries and equity outflows, India's growth story makes its ETFs a compelling play.

In a move to align management responsibilities with its evolving business strategy, Navient Corporation NAVI has revised its leadership structure. As part of the move, Steve Hauber, previously executive vice president (EVP) and chief administrative officer, has been appointed EVP and chief financial officer (CFO), effective immediately.

PSTL's 2025 results show steady expansion, with 216 USPS-leased property buys, near-100% occupancy and a fixed-rate balance sheet.

VRSK shares beat industry gains as subscription shift, SaaS demand and new AI tools drive revenue growth across underwriting and claims.

NEW YORK--(BUSINESS WIRE)---- $AQST #AQST--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. Shares of Aquestive Therapeutics, Inc. (NA.

The biotechnology sector's strong fundamentals and robust innovation could continue to drive outperformance this year, according to Baird analysts. The firm noted that while macroeconomic risks such as rising interest rates remain, the biotechnology sector's underlying drivers are supportive.

INOD's early lead in agentic AI evaluation may fuel 2026 growth as enterprises demand safer, scalable AI systems.

A headline of +50K is lower than the downwardly revised +56K the previous month, but the Unemployment Rate fell -20 bps to +4.4%.